Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
While a new study found that most pediatric hospitalists say they’re happy with ...
CIRM’s new initiative reflects a shift toward platform-based genetic therapy dev...
The deal grants Genentech exclusive global rights to develop and commercialise t...
Quality manufacturing and compliance MVS Omega-3: For food supplements, quality ...
The therapy aims to treat Type I allergic reactions, including anaphylaxis, in p...
Sun Pharma Advanced Research Company (SPARC) announced that the United States ...
Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 10...
India's Foremost Pharma & Biotech Magazine ~ Friendshoring: Pharma's Next Suppl...
Guest Expert Editorial: New U.S. Dietary Guidelines Miss the Mark Michael J. Mar...
Food choices are increasingly recognized as a critical link between individual...
How Outdoor and Indoor Ecotherapy Support Health Outcomes Modern medicine is red...
AstraZeneca Pharma India, a global, science-led biopharmaceutical company, anno...
Blocking microglial Fcγ receptors can prevent dopaminergic neuron loss in Parkin...
Sinorda has completed in vitro functional validation studies of SND006 and plans...
By systematically testing in mouse cells all possible mutations in a key cancer ...
Genentech has agreed to pay SanegeneBio $200 million upfront as well as up to $1...
